ClinVar Miner

Submissions for variant NM_014000.3(VCL):c.1343T>C (p.Leu448Pro)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
New York Genome Center RCV002468451 SCV002764297 uncertain significance Dilated cardiomyopathy 1W; Hypertrophic cardiomyopathy 15 2021-06-11 criteria provided, single submitter clinical testing
Molecular Genetics, Royal Melbourne Hospital RCV003994439 SCV004812513 uncertain significance Primary dilated cardiomyopathy 2023-08-01 criteria provided, single submitter clinical testing This sequence change in VCL is predicted to replace leucine with proline at codon 448, p.(Leu448Pro). The leucine residue is highly conserved (100 vertebrates, UCSC), and is not located in an annotated domain. There is a moderate physicochemical difference between leucine and proline. This variant is absent from the population database gnomAD v2.1 and v3.1. To our knowledge, this variant has not been previously reported in the relevant scientific literature. The variant has been reported in one individual with atrial fibrillation (ClinVar: SCV002764297.1) Computational evidence predicts a deleterious effect for the missense substitution (REVEL = 0.721). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: PM2_Supporting, PP3

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.